Studies suggest that these drugs could help improve fertility outcomes by addressing obesity-related metabolic problems, including hormonal imbalance, insulin resistance and inflammation that can affect reproductive function in both men and women
By binding to GLP-1 receptors in the hypothalamus, it influences the release of hormones that contribute to this effect
This requires individuals to fill the syringe with the recommended dose of medicine from the vial prior to injecting it
In our case series, Patients 1 and 2 started growth hormone replacement in adulthood, when obesity was concurrently addressed with semaglutide
Therefore, clinicians may consider prioritizing GLP-1RAs for individuals at high risk of AF, particularly those with T2DM, along with concomitant hypertension, CAD, heart failure, and obesity